YTE reported $856.61M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 182.55M 20.97M
Agenus AGEN:US USD 88.08M 23.66M
Agios Pharmaceuticals AGIO:US USD -24371000 114.53M
Alnylam Pharmaceuticals ALNY:US USD 523.65M 75.28M
Amgen AMGN:US USD 4.61B 695M
Biocryst Pharmaceuticals BCRX:US USD 125.86M 32.58M
Biogen BIIB:US USD 1.84B 650.7M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Clovis Oncology CLVS:US USD 74.9M 16.63M
Cti Biopharma CTIC:US USD 34.68M 4.22M
Eli Lilly And LLY:US USD 5.47B 200.3M
Exelixis EXEL:US USD 472M 142.87M
Gilead Sciences GILD:US USD 5.12B 917M
Idera Pharmaceuticals IDRA:US USD 9.33M 3.96M
Intercept Pharmaceuticals ICPT:US USD 95.24M 84.25M
Macrogenics MGNX:US USD 61.12M 5.57M
Merk MRK:US USD 10.32B 624M
Mirati Therapeutics MRTX:US USD 212.66M 20.78M
Moderna Inc MRNA:US USD 3.5B 1.31B
Nektar Therapeutics NKTR:US USD 74.49M 3.43M
Neurocrine Biosciences NBIX:US USD 308.6M 8.5M
Newlink Genetics NLNK:US USD 9.35M 1.3M
Novartis NOVN:VX USD 11.05B 378M
Novartis NVS:US USD 11.05B 378M
Pfizer PFE:US USD 19.12B 5.9B
Ptc Therapeutics PTCT:US USD 367.75M 82.44M
Puma Biotechnology PBYI:US USD 68.02M 13.3M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Sarepta Therapeutics SRPT:US USD 367.84M 119.23M
Seattle Genetics SGEN:US USD 682.15M 20.95M
Ultragenyx Pharmaceutical RARE:US USD 248.98M 66.79M
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M
YTE INCY:US USD 856.61M 171.68M